Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance 
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth 
Google Secures Pentagon AI Deal for Classified Projects 
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand 
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat 
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth 
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook 
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement 
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance 
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List 
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings 
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector 
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth 
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth 
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings 
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals 
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds 
MORGANTOWN, W. Va., Feb. 02, 2016 -- Protea Biosciences Group, Inc., (OTCQB:PRGB) announced that the Company will be presenting at the BIO CEO & Investor Conference taking place on February 8-9, 2016 at the Waldorf Astoria Hotel in New York City. Stephen Turner, Chairman and CEO, will present at 8:30 am ET on Monday, February 8, 2016.
To listen to the live audio webcast of the presentation during the event, please visit:
http://www.veracast.com/webcasts/bio/ceoinvestor2016/34103292263.cfm
A replay of the webcast will be available for 90 days after the initial presentation.
Management will be available for one-on-one meetings with conference attendees. Meetings can be arranged through the conference's partnering system at http://www.bio.org/events/conferences/bio-ceo-investor-conference or by contacting the Company at [email protected].
About Protea Biosciences
Protea Biosciences Group, Inc. (OTCQB:PRGB) is a molecular information company providing innovative bio-analytical technology to the pharmaceutical and life science industries. "Molecular information" refers to the generation and bioinformatic processing of very large data sets, obtained by applying the Company's proprietary technology to identify and characterize the proteins, metabolites, lipids and other biomolecules which are the byproducts of all living cells and life forms.
For more Information:
Protea Biosciences Group, Inc., 1311 Pineview Dr., Morgantown, WV 26505 USA
Phone: 304.292.2226 Fax: 304.606.3049
https://proteabio.com/investors
Protea is a registered trademark of Protea Biosciences Group, Inc.
